Chemical Compound

Epoprostenol sodium

CAS Registry Number 61849-14-7
Epoprostenol sodium chemical structure
Primary Record

Epoprostenol sodium

In stock
7,214 g
Purity
99.4 %
CAS
61849-14-7

Compound Identifiers & Properties

CAS
61849-14-7
PubChem CID
6364626
SMILES
CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)[O-])/O2)O)O.[Na+]
Canonical SMILES
CCCCC[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)[O-])O[C@H]2C[C@H]1O.[Na+]

Names & Synonyms

  • Epoprostenol sodium
  • Flolan
  • epoprostenol
  • Cyclo-Prostin
  • Prostacyclin sodium salt
  • Veletri
  • Sodium prostacyclin
  • prostacyclin
  • prostaglandin I2
  • Floran
  • Prostacyclin sodium
  • Epoprostenolsodium
  • Epoprosterol sodium
  • 61849-14-7
  • Prostaglandin X sodium
  • C20H31NaO5
  • Prostaglandin I2 sodium
  • RefChem:57240
  • AC1O4BXH
  • 4K04IQ1OF4
  • UNII-4K04IQ1OF4
  • DTXSID3046617
  • PROSTAGLANDIN I2 Na
  • CHEMBL962
  • Epoprostenol sodium [USAN:BAN]
  • SCHEMBL41344
  • DTXCID1026617
  • EINECS 263-273-7
  • C20H31O5.Na
  • C20H32O5.Na
  • LMHIPJMTZHDKEW-XQYLJSSYSA-M
  • BML1-F10
  • orb1707331
  • Prostaglandin I2 (sodium salt)
  • U-53217A
  • ACT-385781A
  • EX-A7849M
  • C20-H31-Na-O5
  • EPOPROSTENOL SODIUM [JAN]
  • U-53,217A
  • 4UA76
  • EPOPROSTENOL SODIUM [USAN]
  • HMS1361K18
  • HMS3648L14
  • EPOPROSTENOL SODIUM [VANDF]
  • EPOPROSTENOL SODIUM [MART.]
  • Tox21_112431
  • U 53,217A
  • EPOPROSTENOL SODIUM [USP-RS]
  • EPOPROSTENOL SODIUM [WHO-DD]
  • MFCD00135629
  • 3-(4-methylphenyl)prop-2-enenitrile
  • PROSTACYCLIN SODIUM SALT [MI]
  • AKOS024457370
  • CID5282410
  • CID6364626
  • EBC-127030
  • FP27241
  • EPOPROSTENOL SODIUM [ORANGE BOOK]
  • NCGC00167427-01
  • AC-38149
  • CAS-61849-14-7
  • LS-176206
  • 2641S
  • FT-0630728
  • NS00074283
  • V0155
  • A833449
  • Q27259818
  • Sodium (5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dien-1-oate
  • 35121-78-9
  • Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, sodium salt, (5Z,9alpha,11alpha,13E,15S)-
  • Sodium (Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate
  • Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer
  • sodium;(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate
  • (5Z,9a,11a,13E,15S)-6,9-epoxy-11,15-dihydroxy-prosta-5,13-dien-1-oic acid sodium
  • Sodium (5Z,13E,15S)-11beta,15-dihydroxy-9beta,12alpha-6,9-epoxyprosta-5,13-dien-1-oate
  • (5Z,13E,8R,9S,11R,12R,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid sodium salt
  • (5Z,9?,11?,13E,15S)-6,9-epoxy-11,15-Dihydroxy-prosta-5,13-dien-1-oic Acid Sodium Salt; Epoprostenol Sodium; Flolan;
  • (5Z,9|A,11|A,13E,15S)-6,9-epoxy-11,15-Dihydroxy-prosta-5,13-dien-1-oic Acid Sodium Salt
  • 263-273-7
  • 35121-93-8
  • Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, sodium salt (1:1), (5Z,9alpha,11alpha,13E,15S)-
  • PROSTA-5,13-DIEN-1-OIC ACID, 6,9-EPOXY-11,15-DIHYDROXY-, SODIUM SALT, (5Z,9.ALPHA.,11.ALPHA.,13E,15S)-
  • sodium (5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate
  • SODIUM (Z)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-((E)-(3S)-3-HYDROXY-1-OCTENYL)-2H-CYCLOPENTA(B)FURAN-.DELTA.(SUP 2,.DELTA.)-VALERATE
  • Sodium (Z)-5-((3aR,4R,5R,6aS)-5-hydroxy-4-((S,E)-3-hydroxyoct-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-ylidene)pentanoate
  • Sodium(Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate